
Kwality Pharmaceuticals shares jumped over 20% on NSE to Rs 3,134 after the company reported consolidated net profit of Rs 25.6 crore for the June quarter, more than double the Rs 11.9…
Kwality Pharmaceuticals shares jumped over 20% on NSE to Rs 3,134 after the company reported consolidated net profit of Rs 25.6 crore for the June quarter, more than double the Rs 11.9 crore a year ago. Revenue from operations rose 45.7% to Rs 162 crore from Rs 112 crore, NDTV Profit reports.
Operating EBITDA increased 69.1% to Rs 41.1 crore, with margins expanding to 25.3% from 21.8%. The stock has gained over 85% since the start of 2026. Its 52-week range is Rs 1,561 to Rs 3,134.1, giving it a market cap of Rs 3,252 crore.
The usual narrative around pharma stocks is that a single good quarter triggers a buying frenzy, but Kwality Pharma's sustained rally since early 2026 shows broader confidence in its execution. The key test now is whether it can maintain this EBITDA margin above 25% while revenue growth stays near 45%. Watch next quarter's numbers for margin stability, not just profit doubling.
Source: ndtvprofit.com
This story was synthesised by AI from the source linked above.